Insight

Nature 441, 431-436 (25 May 2006) | doi:10.1038/nature04870; Published online 24 May 2006

Nuclear factor-kappaB in cancer development and progression

Michael Karin1

Nuclear factor-kappaB (NF-kappaB) transcription factors and the signalling pathways that activate them are central coordinators of innate and adaptive immune responses. More recently, it has become clear that NF-kappaB signalling also has a critical role in cancer development and progression. NF-kappaB provides a mechanistic link between inflammation and cancer, and is a major factor controlling the ability of both pre-neoplastic and malignant cells to resist apoptosis-based tumour-surveillance mechanisms. NF-kappaB might also regulate tumour angiogenesis and invasiveness, and the signalling pathways that mediate its activation provide attractive targets for new chemopreventive and chemotherapeutic approaches.

  1. Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, California 92093, USA.
    Email: karinoffice@ucsd.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Signal transduction on the fly

Nature Immunology News and Views (01 Oct 2000)

Main navigation

Gateways and databases

Extra navigation

.

SEARCH PUBMED FOR

naturejobs

natureproducts


ADVERTISEMENT